EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases

Anja Strangfeld, Yvette Meissner iD, Anja Weiß, Tatjana Rudi, Angela Zink, Tanja Ellmann, Tim Filla, Peer Aries, Xenofon Baraliakos, Christina Bungartz, Cornelia Glaser, Jörg Henes und 6 weitere

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5867 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Anja Strangfeld und 17 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Health Services Research, German Rheumatism Research Centre Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Registries, Rheumatic Diseases, Pregnancy Complications, Pregnancy Outcome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Rheumatism Research Centre Berlin, Rheumazentrum Rhein-Ruhr e.V., Düsseldorf.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In pharmacoepidemiology, robust data are needed to judge the impact of drug treatment on pregnancy, pregnancy outcomes and breast‐fed infants. As pregnant and breastfeeding women are usually excluded from randomised clinical trials, observational studies are required. One of those data sources are pregnancy registers specifically developed to focus on certain diseases or disease groups. The German Rhekiss register investigates pregnancies in women with chronic inflammatory rheumatic diseases (IRD). Rhekiss is a nationwide, multicentre, longitudinal study, in which women aged 18 years or older with an underlying IRD can be enrolled by a rheumatologist either when planning a pregnancy or in the first half of pregnancy. Data are collected prospectively at regular follow‐up visits. Rheumatologists and patients provide information in a web‐based system before conception (if enrolment was at the time of pregnancy planning), during and after pregnancy. A smartphone app is available for patients. Maternal and clinical information, general laboratory markers, treatment with antirheumatic and other drugs, adverse events, items related to course and outcome of pregnancy and the health of the child are uniformly assessed for all diseases. Individual information on the IRD includes classification criteria, diagnosis‐specific laboratory parameters, clinical parameters and validated instruments to measure disease activity or damage. Furthermore, patient‐reported outcome measures are captured. A total of 2013 individual patients have been enrolled in the register, and data on 1801 completed pregnancies are available. In summary, Rhekiss is a comprehensive and complex register that can answer various research questions about pregnancy in women with chronic IRDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesRheumatic DiseasesPregnancy ComplicationsPregnancy OutcomeAntirheumatic AgentsHumansPregnancyFemaleGermanyLongitudinal StudiesAdultPharmacoepidemiologyAdolescentYoung Adult

Stichwörter der Autor:innen

adverse pregnancy outcomes/pregnancy complicationsdrug treatment safetyinflammatory rheumatic diseasesobservational studypatient‐reported outcome measuresperinatal pharmacoepidemiologypregnancy

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Epidemiology and Health Services Research, German Rheumatism Research Centre Berlin, Berlin, Germany.
  • Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany.
  • Department for Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine-University, Düsseldorf, Germany.
  • Germany and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine-University, Düsseldorf, Germany.
  • Immunologikum Hamburg, Hamburg, Germany.
  • Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany.

ORCID-Profile: Yvette Meissner

Förderung

  • German Rheumatism Research Centre Berlin
  • Rheumazentrum Rhein-Ruhr e.V., Düsseldorf

Zitieren

APA

Strangfeld, A., Meissner, Y., Weiß, A., Rudi, T., Zink, A., Ellmann, T., Filla, T., Aries, P., Baraliakos, X., Bungartz, C., Glaser, C., Henes, J., Lorenz, H. M., Schneider, M., Späthling-Mestekemper, S., Specker, C., Richter, J. G., & Fischer-Betz, R. (2024). Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5867

Vancouver

Strangfeld A, Meissner Y, Weiß A, Rudi T, Zink A, Ellmann T, et al. Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5867

BibTeX
@article{Strangfeld2024,
  author = {Strangfeld, Anja and Meissner, Yvette and Weiß, Anja and Rudi, Tatjana and Zink, Angela and Ellmann, Tanja and Filla, Tim and Aries, Peer and Baraliakos, Xenofon and Bungartz, Christina and Glaser, Cornelia and Henes, Jörg and Lorenz, Hanns-Martin and Schneider, Matthias and Späthling-Mestekemper, Susanna and Specker, Christof and Richter, Jutta G and Fischer-Betz, Rebecca},
  title = {Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5867}
}
Kostenlos starten →